ESOR Special Focus Series
Alzheimer's Disease 2
Lectures
Advanced MRI Techniques in AD (Functional MRI (fMRI) Diffusion Tensor Imaging (DTI, ASL)
40:00Sven Haller
Quantitative MRI and the use of AI Algorithms for Image Analysis and Diagnosis of AD
40:00Dennis Hedderich
Current and Emerging Therapies for AD
40:00Giovanni Frisoni
Amyloid cerebral angiopathy
40:00Gregory Kuchcinski
Side Effects of New Treatments :Amyloid-Related Imaging Abnormalities (ARIA)
40:00Frederik Barkhof
Organisation challenges of monitoring AD patients with the new treatments.
40:00Nuria Bargallo
COURSE INFORMATION
Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder that increasingly burdens patients, caregivers, and healthcare systems. Radiologists play a crucial role in the diagnosis and monitoring of AD, primarily through the use of advanced imaging modalities such as MRI and PET scans. However, significant gaps and barriers exist in the current training and practices of radiologists, which need to be addressed to improve patient outcomes.
This course combines evidence-based educational strategies with flexible, accessible delivery methods to create an engaging, learner-centred experience. By integrating interactive elements, real-world application, and opportunities for learner influence, the course ensures that participants not only acquire knowledge but also develop the skills and confidence to apply it in their clinical practice.
Attention: You need to attend both days to receive a CME certificate!
See here for more information.
LEARNING OBJECTIVES
- Understand diagnostic methods and biomarkers
- Be updated on the use of advanced imaging tools
- Be familliar with the use of MRI and PET scans in the treament of Alzheimer’s Disease
- Understand the importance of monitoring of Anti-Amyloid Treatment effects
PROGRAMME ONLINE
Friday, September 5, 2025
| 12:30 – 13:10 | Advanced MRI Techniques in AD (fMRI, DTI, ASL) Sven Haller, Geneva/CH |
| 13:10 – 13:50 | Quantitative MRI and the use of AI Algorithms for Image Analysis and Diagnosis of AD Dennis Hedderich, Munich/DE |
| 13:50 – 14:30 | Current and Emegerging Therapies for AD Giovanni Frisoni, Geneva/CH |
| 14:30 – 15:00 | Q&A Session |
| 15:00 – 15:30 | Break |
| 15:30 – 16:10 | Amyloid cerebral angiopathy Grégory Kuchcinski, Lille/FR |
| 16:10 – 16:50 | Side Effects of New Treatments: Amyloid-Related Imaging Abnormalities (ARIA) Frederik Barkhof, London/UK |
| 16:50 – 17:30 | Organisation challenges of monitoring AD patients with the new treatments Nuria Bargallo, Barcelona/ES |
| 17:30 – 18:00 | Q&A Session |